CR9859A - Inhibidores de la enzima integrasa de vih - Google Patents
Inhibidores de la enzima integrasa de vihInfo
- Publication number
- CR9859A CR9859A CR9859A CR9859A CR9859A CR 9859 A CR9859 A CR 9859A CR 9859 A CR9859 A CR 9859A CR 9859 A CR9859 A CR 9859A CR 9859 A CR9859 A CR 9859A
- Authority
- CR
- Costa Rica
- Prior art keywords
- inhibitors
- integrated hiv
- hiv enzyme
- enzyme
- integrated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente invencion se refiere a compuestos de la formula (I), y sus sales y solvatos farmaceuticamente aceptables, su sintesis, y su uso como moduladores o inhibidores de la enzima integrasa del virus de la inmunodeficiencia humano ("VIH").
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72448405P | 2005-10-07 | 2005-10-07 | |
US73070105P | 2005-10-26 | 2005-10-26 | |
US76160506P | 2006-01-24 | 2006-01-24 | |
US82395406P | 2006-08-30 | 2006-08-30 | |
US82637906P | 2006-09-20 | 2006-09-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR9859A true CR9859A (es) | 2008-06-20 |
Family
ID=37684843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR9859A CR9859A (es) | 2005-10-07 | 2008-02-04 | Inhibidores de la enzima integrasa de vih |
Country Status (21)
Country | Link |
---|---|
US (1) | US20070099915A1 (es) |
EP (1) | EP1934220A1 (es) |
JP (1) | JP2009511463A (es) |
KR (1) | KR20080042171A (es) |
AP (1) | AP2008004400A0 (es) |
AR (1) | AR061398A1 (es) |
AU (1) | AU2006300926A1 (es) |
BR (1) | BRPI0616657A2 (es) |
CA (1) | CA2623506A1 (es) |
CR (1) | CR9859A (es) |
EA (1) | EA200800758A1 (es) |
IL (1) | IL189939A0 (es) |
MA (1) | MA29855B1 (es) |
NL (1) | NL2000255A1 (es) |
NO (1) | NO20081230L (es) |
PE (1) | PE20070494A1 (es) |
RS (1) | RS20080141A (es) |
SV (1) | SV2009002864A (es) |
TW (1) | TW200800219A (es) |
UY (1) | UY29843A1 (es) |
WO (1) | WO2007042883A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1751157B1 (en) * | 2004-04-26 | 2007-10-03 | Pfizer Inc. | Inhibitors of the hiv integrase enzyme |
EP2234608A2 (en) | 2007-12-11 | 2010-10-06 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
CN102532021B (zh) * | 2012-01-31 | 2013-10-16 | 天津大学 | 2-烷氧基-3,4-二取代异喹啉-1(2h)-酮类衍生物的制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ194747A (en) * | 1979-08-29 | 1988-11-29 | Schering Ag | 9h-pyrido(3,4-b)indol-3-ylcarboxylic acid derivatives |
US5616609A (en) * | 1991-08-08 | 1997-04-01 | Ikekawa; Tetsuro | Carcinostatic compound and production thereof |
EP0713877A1 (en) * | 1993-07-19 | 1996-05-29 | LUO, Xuande | Qinghaosu derivatives against aids |
US6057297A (en) * | 1996-08-06 | 2000-05-02 | Polifarma S.P.A. | Inhibitor compounds of zinc-dependent metalloproteinases associated with pathological conditions, and therapeutic use thereof |
FR2754262B1 (fr) * | 1996-10-08 | 1998-10-30 | Synthelabo | Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique |
US6403347B1 (en) * | 1998-02-03 | 2002-06-11 | Merck & Co., Inc. | HIV integrase inhibitors |
WO2001027309A1 (en) * | 1999-10-13 | 2001-04-19 | Merck & Co., Inc. | Hiv integrase inhibitors |
CA2412985A1 (en) * | 2000-06-16 | 2001-12-27 | Bristol-Myers Squibb Company | Hiv integrase inhibitors |
PA8586801A1 (es) * | 2002-10-31 | 2005-02-04 | Pfizer | Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso |
EP1590349A1 (en) * | 2003-01-27 | 2005-11-02 | Pfizer Inc. | Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use |
EP1751157B1 (en) * | 2004-04-26 | 2007-10-03 | Pfizer Inc. | Inhibitors of the hiv integrase enzyme |
CA2578841A1 (en) * | 2004-09-07 | 2006-03-16 | Pfizer Inc. | Inhibitors of the hiv integrase enzyme |
-
2006
- 2006-09-25 CA CA002623506A patent/CA2623506A1/en not_active Abandoned
- 2006-09-25 KR KR1020087008162A patent/KR20080042171A/ko not_active Application Discontinuation
- 2006-09-25 EA EA200800758A patent/EA200800758A1/ru unknown
- 2006-09-25 WO PCT/IB2006/002735 patent/WO2007042883A1/en active Application Filing
- 2006-09-25 BR BRPI0616657-1A patent/BRPI0616657A2/pt not_active Application Discontinuation
- 2006-09-25 EP EP06808923A patent/EP1934220A1/en not_active Withdrawn
- 2006-09-25 AU AU2006300926A patent/AU2006300926A1/en not_active Abandoned
- 2006-09-25 JP JP2008534098A patent/JP2009511463A/ja not_active Withdrawn
- 2006-09-25 AP AP2008004400A patent/AP2008004400A0/xx unknown
- 2006-09-25 RS RSP-2008/0141A patent/RS20080141A/sr unknown
- 2006-10-03 NL NL2000255A patent/NL2000255A1/nl active Search and Examination
- 2006-10-04 AR ARP060104374A patent/AR061398A1/es not_active Application Discontinuation
- 2006-10-05 TW TW095137139A patent/TW200800219A/zh unknown
- 2006-10-05 PE PE2006001216A patent/PE20070494A1/es not_active Application Discontinuation
- 2006-10-06 US US11/539,205 patent/US20070099915A1/en not_active Abandoned
- 2006-10-06 UY UY29843A patent/UY29843A1/es not_active Application Discontinuation
-
2008
- 2008-02-04 CR CR9859A patent/CR9859A/es not_active Application Discontinuation
- 2008-03-04 IL IL189939A patent/IL189939A0/en unknown
- 2008-03-07 NO NO20081230A patent/NO20081230L/no not_active Application Discontinuation
- 2008-04-07 SV SV2008002864A patent/SV2009002864A/es not_active Application Discontinuation
- 2008-04-07 MA MA30821A patent/MA29855B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
PE20070494A1 (es) | 2007-06-13 |
WO2007042883A1 (en) | 2007-04-19 |
NO20081230L (no) | 2008-04-08 |
JP2009511463A (ja) | 2009-03-19 |
BRPI0616657A2 (pt) | 2011-06-28 |
RS20080141A (en) | 2009-07-15 |
IL189939A0 (en) | 2008-08-07 |
EA200800758A1 (ru) | 2008-08-29 |
EP1934220A1 (en) | 2008-06-25 |
US20070099915A1 (en) | 2007-05-03 |
NL2000255A1 (nl) | 2007-04-11 |
CA2623506A1 (en) | 2007-04-19 |
SV2009002864A (es) | 2009-02-19 |
TW200800219A (en) | 2008-01-01 |
AU2006300926A1 (en) | 2007-04-19 |
UY29843A1 (es) | 2007-05-31 |
AP2008004400A0 (en) | 2008-04-30 |
AR061398A1 (es) | 2008-08-27 |
MA29855B1 (fr) | 2008-10-03 |
KR20080042171A (ko) | 2008-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0510319A (pt) | inibidores da enzima integrase de hiv | |
UY29927A1 (es) | Derivados sustituidos de la 5-fenil-2-tioxo-imidazolin-4-ona y de la 5-fenil-2-amino-imidazolidin-4-ona y sus sales, composiciones y aplicaciones | |
UY30274A1 (es) | Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones | |
UY30426A1 (es) | Derivados sustituidos del 3-(4-metoxi-fenil)-3h-isoindol-1-ilamina trifluoroacetado, sus sales o solvatos farmaceuticamente aceptables, formulaciones farmacéuticas y aplicaciones. | |
UY27350A1 (es) | Azaindoles | |
AR055076A1 (es) | Derivados de1,1-dioxido de 1,4-benzotiazepina,procedimiento para prepararlos,composiciones farmaceuticas que los contienen y usos en terapeutica. | |
TN2010000212A1 (en) | Inhibitors of human immunodeficiency virus replication | |
CL2011001658A1 (es) | Compuestos derivados de sulfonamidas, moduladores de los canales de sodio; composición farmacéutica que los comprende; y su uso en el tratamiento del dolor. | |
CR10149A (es) | Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico | |
CO6741203A2 (es) | Derivados de biciclo[3,2,1]octilamida y sus usos | |
BRPI0819328A8 (pt) | Compostos inibidores de replicação de vírus da imunodeficiência humana, composição farmacêutica e uso dos ditos compostos | |
GT200600134A (es) | Compuestos novedosos de derivados de aminosulfonilo | |
BRPI0408347A (pt) | derivados de pirimidina | |
NI200900040A (es) | Derivados de quinazolinona 5-substituidos como agentes antitumorales. | |
UY30408A1 (es) | Derivados sustituidos del acetato de 8-(4-metoxifenil)-2,3,4,8-tetrahidroimidazo-[1,5-a]-pirimidin-6-amina, composiciones farmacéuticas y aplicaciones | |
MA31889B1 (fr) | N-phenyl -bipyrrolidine-urees substituees et utilisation therapeutique de celles-ci | |
ECSP088677A (es) | Piperazinas y piperidinas como potenciadores 157 del mglur5 | |
CO6190616A2 (es) | Carboxamidas n-fenil-bipirrolidina sustituidas y su uso terapeutico | |
ECSP089019A (es) | Inhibidores de sulfonamida tricíclicos, fusionados del gama secretasa | |
CR9722A (es) | Derivados de benzilpiperazina y su uso medico | |
PA8568101A1 (es) | Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso | |
ECSP088603A (es) | Nuevas n-(fluor-pirazinil)-fenilsulfonamidas como moduladores del receptor de quimioquina ccr4 | |
UY29394A1 (es) | Derivados sustituidos de n-(5-(2-propilamino.1.hidroxietil)-2-hdroxifenil) metano sulfonamida, composiciones farmacéuticas que lo contienen y aplicaciónes. | |
DOP2006000248A (es) | Acido 1-(1-(2-etoxietil)-3-etil-7-(4-metilpiridin-2-ilamino)-1h- pirazolo[4,3-d]pirimidin-5-il)piperidina-4-carboxílico y las sales del mismo. | |
CR9859A (es) | Inhibidores de la enzima integrasa de vih |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |